Drug Trial Radar · NCT07197866
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Sep 30, 2025
Primary completion
May 3, 2029
Study completion May 17, 2029
Sponsor
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D LLCTeva (TEVA)
- Sponsor type
- Industry
- First posted
- Sep 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the trial is to further describe the safety and tolerability of TEV-56286. The planned total duration of the trial is approximately 100 weeks.
Conditions
- Multiple System Atrophy
Interventions
TEV-56286Drug
administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants experiencing an adverse eventTime frame: Baseline to Week 100
- Number of participants who withdrew from the trial due to an adverse eventTime frame: Baseline to Week 100
Locations
41 sites in 7 countries. Site status is shown where the registry gives one.
Teva Investigational Site 15554
La Jolla, California · Recruiting
Teva Investigational Site 15544
Boca Raton, Florida · Recruiting
Teva Investigational Site 15555
Tampa, Florida · Recruiting
Teva Investigational Site 15550
Chicago, Illinois · Recruiting
Teva Investigational Site 15546
Kansas City, Kansas · Recruiting
Teva Investigational Site 15549
New York, New York · Recruiting
Teva Investigational Site 15551
New York, New York · Recruiting
Teva Investigational Site 15553
Durham, North Carolina · Recruiting
Teva Investigational Site 15548
Pittsburgh, Pennsylvania · Recruiting
Teva Investigational Site 15543
Spokane, Washington · Recruiting
Teva Investigational Site 35290
Bordeaux, France · Recruiting
Teva Investigational Site 35289
Marseille, France · Recruiting
Teva Investigational Site 35291
Paris, France · Recruiting
Teva Investigational Site 35292
Toulouse, France · Recruiting
Teva Investigational Site 32818
Dresden, Germany · Recruiting
Teva Investigational Site 32822
Düsseldorf, Germany · Recruiting
Teva Investigational Site 32825
Kassel, Germany · Recruiting
Teva Investigational Site 32824
Marburg, Germany · Recruiting
Teva Investigational Site 32820
München, Germany · Recruiting
Teva Investigational Site 32819
Münster, Germany · Recruiting
Teva Investigational Site 80203
Haifa, Israel · Recruiting
Teva Investigational Site 80204
Tel Aviv, Israel · Recruiting
Teva Investigational Site 30299
Bologna, Italy · Recruiting
Teva Investigational Site 30297
Catania, Italy · Recruiting
Teva Investigational Site 30298
Milan, Italy · Recruiting
Teva Investigational Site 30294
Padova, Italy · Recruiting
Teva Investigational Site 30296
Roma, Italy · Recruiting
Teva Investigational Site 30295
Salerno, Italy · Recruiting
Teva Investigational Site 84140
Chiba, Japan · Recruiting
Teva Investigational Site 84139
Fuchū, Japan · Recruiting
Teva Investigational Site 84137
Niigata, Japan · Recruiting
Teva Investigational Site 84138
Sagamihara, Japan · Recruiting
Teva Investigational Site 84141
Sanda-shi, Japan · Recruiting
Teva Investigational Site 84135
Sendai, Japan · Recruiting
Teva Investigational Site 31324
Barcelona, Spain · Recruiting
Teva Investigational Site 31323
Barcelona, Spain · Recruiting
Teva Investigational Site 31321
Barcelona, Spain · Recruiting
Teva Investigational Site 31327
Madrid, Spain · Recruiting
Teva Investigational Site 31320
Pamplona, Spain · Recruiting
Teva Investigational Site 31322
Seville, Spain · Recruiting
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.